Adeno-associated virus (AAV)-based viral vectors used in human gene therapy can trigger innate immune pathways, leading to the initiation of adaptive immune responses. A new review article published in the journal Human Gene ...
12 hours ago
0
0
A study from the University of Michigan has identified a potential new treatment for food allergies in inulin, a naturally occurring plant fiber commonly used as a supplement, a prebiotic in soda, a replacement for sweeteners ...
Jul 9, 2024
0
47
In 2022, about 10.6 million people worldwide contracted tuberculosis, including 1.3 million children. The diagnosis of tuberculosis in adults is usually made from sputum (sputum) in the microbiology laboratory. In children, ...
Jul 9, 2024
0
19
Researchers have detected anaerobic and aerobic bacteria in commercial tattoo and permanent makeup inks. The findings, reported in Applied and Environmental Microbiology demonstrate that the inks could be a source of human ...
Jul 2, 2024
0
0
Several people across the country have recently been hospitalized after consuming mushroom gummies distributed by Australian brand Uncle Frog and made in the United States. Their reported symptoms included elevated heart ...
Jun 29, 2024
0
0
Around the time of the untimely death of Freddie Gray, a 25-year-old Black man in police custody, researchers from Johns Hopkins University were collecting data for Communities CARING, a study that examined the relationship ...
Jun 27, 2024
0
0
When older adults fall at home, every second counts—especially when they are alone.
Jun 27, 2024
0
2
Fewer than 1% of people who get the flu every year get tested in part because most tests require trained personnel and expensive equipment. Now researchers have developed a low-cost paper strip test that could allow more ...
Jun 19, 2024
0
0
The prevalence of allergic diseases has been increasing globally, posing significant public health challenges. Allergic reactions can range from mild, such as allergic rhinitis (AR) and conjunctivitis, to severe, like allergic ...
Jun 18, 2024
0
57
Earlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza.
Jun 15, 2024
0
0
